Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI.

Nature. 2006 Sep 14;443(7108):214-7. Epub 2006 Sep 6.

PMID:
16957739
2.

p53-dependent cell cycle control: response to genotoxic stress.

Schwartz D, Rotter V.

Semin Cancer Biol. 1998;8(5):325-36. Review.

PMID:
10101798
3.

Could p53 be a target for therapeutic suppression?

Komarova EA, Gudkov AV.

Semin Cancer Biol. 1998;8(5):389-400. Review.

PMID:
10101804
4.

p53 modulation of the DNA damage response.

Helton ES, Chen X.

J Cell Biochem. 2007 Mar 1;100(4):883-96. Review.

PMID:
17031865
5.

The Arf/p53 pathway in cancer and aging.

Matheu A, Maraver A, Serrano M.

Cancer Res. 2008 Aug 1;68(15):6031-4. doi: 10.1158/0008-5472.CAN-07-6851. Review.

6.

Transcriptional targets of p53 that regulate cellular proliferation.

Brown L, Boswell S, Raj L, Lee SW.

Crit Rev Eukaryot Gene Expr. 2007;17(1):73-85. Review.

PMID:
17361486
7.

A role for the tumour suppressor gene p53 in regulating neuronal apoptosis.

Hughes PE, Alexi T, Schreiber SS.

Neuroreport. 1997 Oct 20;8(15):v-xii. Review.

PMID:
9351639
8.

The ARF tumour suppressor.

Gallagher SJ, Kefford RF, Rizos H.

Int J Biochem Cell Biol. 2006;38(10):1637-41. Epub 2006 Feb 28. Review.

PMID:
16600663
9.

Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors.

Komarova EA, Gudkov AV.

Biochem Pharmacol. 2001 Sep 15;62(6):657-67. Review.

PMID:
11556286
10.

The role of DNA damage responses in p53 biology.

Speidel D.

Arch Toxicol. 2015 Apr;89(4):501-17. doi: 10.1007/s00204-015-1459-z. Epub 2015 Jan 25. Review.

PMID:
25618545
11.

Tumour suppression by p53: a role for the DNA damage response?

Meek DW.

Nat Rev Cancer. 2009 Oct;9(10):714-23. doi: 10.1038/nrc2716. Epub 2009 Sep 4. Review.

PMID:
19730431
12.

Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.

Teodoro JG, Evans SK, Green MR.

J Mol Med (Berl). 2007 Nov;85(11):1175-86. Epub 2007 Jun 23. Review.

PMID:
17589818
13.

The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression.

Wynford-Thomas D, Jones CJ, Wyllie FS.

Biol Signals. 1996 May-Jun;5(3):139-53. Review.

PMID:
8864059
14.

p53 and tumour viruses: catching the guardian off-guard.

Neil JC, Cameron ER, Baxter EW.

Trends Microbiol. 1997 Mar;5(3):115-20. Review.

PMID:
9080610
15.

Two faces of p53: aging and tumor suppression.

Rodier F, Campisi J, Bhaumik D.

Nucleic Acids Res. 2007;35(22):7475-84. Epub 2007 Oct 16. Review.

16.

Radiation induced dynamic mutations and transgenerational effects.

Niwa O.

J Radiat Res. 2006;47 Suppl B:B25-30. Review.

17.

[DNA radiation damage and p53].

Qian X, Zhu YB.

Sheng Li Ke Xue Jin Zhan. 2005 Oct;36(4):379-81. Review. Chinese. No abstract available.

PMID:
16408786
18.

[Function of tumor suppressor p53 and its role in antiviral immunity].

Yan WJ, Wu KB, Ma ZY.

Bing Du Xue Bao. 2012 Jun;28(4):462-70. Review. Chinese.

PMID:
22978174
19.

Pathologies associated with the p53 response.

Gudkov AV, Komarova EA.

Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a001180. doi: 10.1101/cshperspect.a001180. Epub 2010 Apr 7. Review.

20.

p53--a Jack of all trades but master of none.

Junttila MR, Evan GI.

Nat Rev Cancer. 2009 Nov;9(11):821-9. doi: 10.1038/nrc2728. Epub 2009 Sep 24. Review.

PMID:
19776747

Supplemental Content

Support Center